Can mirtazapine cause a rash?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Mirtazapine Cause a Rash?

Yes, mirtazapine can cause a rash, including severe and potentially fatal skin reactions that require immediate medical attention and drug discontinuation. 1

Severity and Types of Skin Reactions

The FDA drug label explicitly warns that mirtazapine may cause severe skin reactions that can be life-threatening 1. These reactions include:

  • Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
  • Stevens-Johnson syndrome
  • Bullous dermatitis
  • Erythema multiforme
  • Toxic epidermal necrolysis

These severe reactions may present with rash accompanied by fever, swollen glands, and multi-organ involvement affecting the liver, kidney, lung, and heart 1. The FDA label states these reactions "may sometimes be fatal" 1.

Clinical Action Required

If a patient develops a rash while taking mirtazapine, tell them to contact their healthcare provider immediately 1. This is particularly urgent if the rash is accompanied by:

  • Fever
  • Swollen lymph nodes
  • Systemic symptoms suggesting organ involvement

Mirtazapine is contraindicated in patients with known hypersensitivity to mirtazapine or its excipients, specifically because severe skin reactions have been documented 1.

Important Clinical Context

While the 2008 American College of Physicians guideline on second-generation antidepressants lists common adverse effects (constipation, diarrhea, dizziness, headache, insomnia, nausea, sexual dysfunction, and somnolence), it does not specifically mention rash 2. However, the FDA drug label takes precedence as the authoritative source for safety information, and it clearly identifies severe skin reactions as a serious adverse effect requiring immediate attention.

The key clinical pitfall is dismissing a rash as minor or unrelated to mirtazapine. Any rash developing during mirtazapine therapy warrants evaluation for potential severe cutaneous adverse reactions, especially if systemic symptoms are present.

Related Questions

Can a 76-year-old woman restart mirtazapine four days after an abrupt discontinuation, and what dose should be used?
Can imipramine be combined with a low-dose Remeron (mirtazapine)?
In a 77‑year‑old woman with long‑standing intense generalized pruritus without rash, chronic severe constipation, severe depression intolerant to antidepressants, recent hip dislocation with pain, and current medications including lorazepam, oxycodone, mirtazapine, a first‑generation antihistamine, enalapril, omeprazole, and zolpidem, with year‑to‑year normal laboratory results except a mild anemia today due to low oral intake, what laboratory investigations should be ordered and what is the most likely cause of her itching?
Is it safe to taper mirtazapine by reducing the dose by 7.5 mg every four weeks until discontinuation?
Should mirtazapine be discontinued before a colonoscopy?
Do American academic pediatric societies recommend the use of NIDO milk powder for children over 12 months of age?
What pH range maintains myoglobin solubility?
Does Tremfya (guselkumab) carry a risk of rash?
When is dexamethasone indicated in viral infections?
What does an elevated vitamin B12 level with low red blood cell count, mildly increased mean corpuscular volume, increased mean corpuscular hemoglobin, and elevated neutrophil count indicate?
Given an elevated peak systolic velocity in the right common iliac artery on an abdominal aortic aneurysm screening ultrasound suggesting a hemodynamically significant stenosis, should a contrast‑enhanced computed tomography angiography of the abdomen and pelvis with runoff assessment be performed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.